Prognostic significance of prostate specific antigen in comparison with histological grade of prostatic adenocarcinoma: A Hospital based study.

  • Mohanrao Nandam Department of social and preventive medicine , Narayana Medical College, Chinthareddypalem, Nellore, Andhra Pradesh(India)
  • Vissa Shanthi Department of social and preventive medicine , Narayana Medical College, Chinthareddypalem, Nellore, Andhra Pradesh(India)
  • Bhavana Grandhi Department of social and preventive medicine , Narayana Medical College, Chinthareddypalem, Nellore, Andhra Pradesh(India)
  • Syama Sundara Rao Byna Department of social and preventive medicine , Narayana Medical College, Chinthareddypalem, Nellore, Andhra Pradesh(India)
  • Vijaya Lakshmi Muramreddy Department of social and preventive medicine , Narayana Medical College, Chinthareddypalem, Nellore, Andhra Pradesh(India)
  • Jyothi Conjeevaram Department of social and preventive medicine , Narayana Medical College, Chinthareddypalem, Nellore, Andhra Pradesh(India)
Keywords: Prostate specific antigen, Gleason histopathological grade, Prostatic adeno carcinoma, prostatic lesions

Abstract

Background: Prostate gland disease causes significant morbidity in elderly males. Our objective of the study was to evaluate the histopathological spectrum of prostatic lesions in correlation with prostate specific antigen and compare the prostate specific antigen with histological grade of prostatic adenocarcinoma.Methods:The present retrospective study was carried in the department of pathology, Narayana Medical College & Hospital, Nellore, and Andhra Pradesh, India from January 2015 to December 2015. 119 Prostatic biopsy specimens were analyzed histopathologically for diagnosis of types of prostatic lesion and correlated with serum PSA level. Prostatic adeno carcinomas were graded according to Gleason histological grading. Gleason’s grading of tumors was correlated with serum PSA levelsResult:Out of 119 patients, 95 cases had benign prostatic hyperplasia, 17 cases had prostatic adenocarcinoma, 7 cases had prostatitis. In our study, the maximum number of BPH cases (51.58%) showed PSA levels < 4ng/ml.Most of prostatic adenocarcinoma (82.35%) displayed PSA levels >10ng/ml. 5 cases (71.43%) of prostatitis showed PSA levels of 4-10ng/ml.Maximum cases of grade 2 and grade 3 prostatic adenocarcinoma had PSA range of 20-49 .99ng/ml.      Conclusion: Benign prostatic hyperplasia is the most commonly diagnosed prostatic lesions. Investigation like serum PSA level detection can aid in the diagnosis, but accurate diagnosis of non-neoplastic and neoplastic lesions of prostate can be made by histopathological study of prostate biopsy. There is a positive relation was seen between higher levels of PSA and Gleason histopathological grade.

Author Biography

Mohanrao Nandam, Department of social and preventive medicine , Narayana Medical College, Chinthareddypalem, Nellore, Andhra Pradesh(India)
department of pathology,associate professor

References

1. Anunobi CC, Akinde OR, Elesha SO, Daramola AO, Tijani KH, Ojewola RW. Prostate diseases in Lagos, Nigeria: a histologic study with PSA correlation. Nigerian postgrad Med J. 2011; 8(2); 98-104.
2. Denis LJ. Diagnosing benign prostate hyperplasia versus prostate cancer. Br J Urol 1995:75(suppl1); 17-23.
3. Akdas A. Turkan T, Turkeil, Cerviki, Biren T and Gurmen N. The diagnostic accuracy of digital rectal examination , transrectal ultrasonography, prostate specific antigen (PSA) density in prostate carcinoma. Br J Urol 1995:76:54-6.
4. Radiae S. Prostate cancer molecular staging. State of-the-Art in prostate and breast cancer treatment.European school of Oncology. Advanced course. September, 2002: Education boo. 2000 ;101-4.
5. Stamey TA, Yang N, hay AR, Mc Neal JE, Frina FS, Red wine E. Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med.1987:317:909-16.
6. WalshPC.Why make an early diagnosis of prostate cancer. JUrol 1990:147:853-4.
7.Thompson IM, Pauler DK, Goodmann PJ, et al. Prevalence of prostate cancer among men with a prostate specific antigen level=4.0ng/ml.Journal of Medicine .2004:350(22):2239-2246.
8. Lyn NNK, Collins GN, Alex Ak et al. A comparative analysis of the role of prostate specific antigen parameters in clinical practice. The Prostate Journal 2000:2(4):205-210.
9. Mwaakyoma HA et al. Correlation of Gleason”s score and pretreatment prostate specific antigen in patients. Professional Med J Jun 2010; 17(2):235-240.
10. Jyotisapre KA, Agnihotri AS. et al: Utility of prostate specific antigen in different prostatic lesion: pathology and laboratory medicine: June 2011; 3(1):18-23.
11. Haroun AA, Hadidy AS, Awwad ZM et al: Utility of free PSA serum level and its related parameters in the diagnosis of prostate cancer. Soudi journal of kidney diseases and transplantation. 2011:22(2);291-297.
12. Djavan B. Optimal predictors of prostate cancer on repeat prostate biopsy; a prospective study of 1051 men . Journal of urology (UNITED STATES) 2000; 163(4) ;1144-8.
13. Bhatt JV, Shah JM, Shah FR. Prostate –Assessment to management 2008.
14. Khan IA, Muhammadnasiret al: Carcinoma of prostate in clinically benign enlarged gland; J Ayub med coll Abottabad 2008; 20(2) ;90-92.
15. Zivkovic S et al: Correlation prostate specific antigen and histopathological difference of prostate carcinoma; arch oncol 2004; 12(3);148-51.
16. Shanthi V et al. prognostic importance of prostate specific antigen in assessing histological grade of prostatic adenocarcinoma. Int J Med Res Rev 2015; 3(3):268-272.
17. Jackson LA, McGrowder DA, Alexander-Lindo R. Prostate Specific antigen and Gleason Score in men with prostate cancer at a private Diagnostic radiology centre in Western Jamaica, Asian Pacific journal of cancer prevention.2012;13;1453-1456.
Published
2017-12-18
Issue
Vol 4 No 6 (2017)
Section
Original Article

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).